Test type : Antibody (one drop of finger stick blood, 15 minutes detection time)
Packing : Individually packed 10 test kits per box
Available Certificates : FDA registered, CE, ISO 13485:2016
MOQ : 8000 pcs / 1 Pallet
PANODYNE - The new rapid lgM-lgG combined antibody test* for COVID-19 from Multibrands International is now available to test for the detection of lgG and lgM antibodies of coronavirus from a small specimen of human serum, plasma or whole blood. The detection works with proteins to indicate if a person's immune system has responded with the COVID-19 virus to indicate infection.
Hello,Sir Or Madam! Good News For You! I'm Tony Tsui, The Executive Of Runway Group. We Runway Group have successfully R&D the New Very Hot Hot Hot Product :COVID-19 Antibody Rapid Test kits .This Has been used and inspected by many hospitals In Wuhan And China Other Cities ,Now,our test kit FDA&CE Approved Certificates,it can sell all the world. It Is very hot product For many countries ,many governments ,many Hospitals for all the World! Now We Wanted The Exclusive Agent In Your Country in all the world! CIFCustomer Country Unit Price :xx Usd/pcs ,MOQ:0.2million Pcs ,3-5 working days shipment. When We Received 100% Prepayment By T/T or L/C AT SIGHT. If you are Interesting this hot product ,pls send me Email:tony.chau2008@hotmail.com for the details introduction and instruction video. You're Welcome,any time anywhere!!! Thank You Very Much! Best Regards Tony Tsui Runway Group
Hello,Sir Or Madam! Good News For You! I'm Tony Tsui, The Executive Of Runway Group. We Runway Group have successfully R&D the New Very Hot Hot Hot Product :COVID-19 Antibody Rapid Test kits .This Has been used and inspected by many hospitals In Wuhan And China Other Cities ,Now,our test kit FDA&CE Approved Certificates,it can sell all the world. It Is very hot product For many countries ,many governments ,many Hospitals for all the World! Now We Wanted The Exclusive Agent In Your Country in all the world! CIFCustomer Country Unit Price :xx Usd/pcs ,MOQ:0.2million Pcs ,3-5 working days shipment. When We Received 100% Prepayment By T/T or L/C AT SIGHT.
Certification - Test report-Certified Daily manufacturer output - 200,000 Price - $15.00 per test
COVID-19 (2019-nCoV) Coronavirus IgG/IgM Rapid Test Kit Principle: based on Colloidal Gold Method, to detect COVID-19 IgG/IgM Antibody in serum, plasma, whole blood qualitatively. Easy to operate, results can be obtained in 15 minutes. Component: 25 tests cassttes/ 25 dropper/ 25 tubes of dilution buffer/25 Alcohol pad/ 25 Lancet/ 1 manual Certificate: CE, ISO13485, ISO9001
Covid-19 IgG/IgM Antibody test kit, 10 minute results 98% accuracy IgG, 96% IgM. Zero cross reactivity with Influenza A&B, Chlamydia, HIV, Hepatitis, EB, Measles, Mumps. Independently verified.
COVID-19 Rapid Test Kit IgG + IgM (Colloidal Gold) comes in packs of 40 tests and contains: GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva Price and Minumum Quantity Price FOB in USD: negotiable 0.8 to 1.8Minimum Order Qty: None Pieces Production Capacity: 3,000,000/monthPackaging: 20 Tests/kit, 30 Kits/box, 12 Boxes/pallet Sample: Available. Sample Cost Born By Supplier Product Model And Origin Brand: GENEDIAModel: 643G-S (Saliva) Seller Code: Genedia w covid 19 agHS Code: 3002.15 Standards: Ce Competitive Advantages Allow wider testing with fast test time (10 minutes) All necessary materials provided / no equipment needed Sensitivity: 93.33%, specificity: 100% Free sample. no moq. price is negotiable. customized packing. Other Details 20 tests / kit 24 months from the date of manufacture 2 ~ 30c(35.6 ~ 86f) available for room temperature deliver In stock. fast delivery. 1 x Instructions for Use Manual 40 x Test Cassettes 1 x Buffer 40 x Dropper
Angiten-COVID-19 Virus Test Kit (Colloidal Gold) Quantity of box: 25 persons/box Brand: Easysweet NMPA (National Medical Products Administration): Approved CE: with CE mark BfArM: listed Test Method: Antigen Test Result Time: 10-15 mins Sample Type: Nasal Swab Sensitivity: 96.70% Specificity: 100% Accuracy: 98.94% Shelf Life: 24 months Storage Temperature: 2-30 Degree Celsius Country of Origin: Made in China Additional Information: Production Capacity: 1 million Delivery Time: 10-15 days Packaging Details: 25 tests in a pack, 40packs/ carton Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only. Price and Minumum Quantity Price FOB in USD: NegotiableMinimum Order Qty: 10000 Production Capacity: 1000000Packaging: 25 Persons/box Sample: Available. Sample Cost Born By Buyer Product Model And Origin Brand: Easysweet HS Code: 3822009020 Standards: Ce Competitive Advantages Best price with shortest delivery time Best price with shortest delivery time Best price with shortest delivery time Best price with shortest delivery time Other Details Angiten-covid-19 virus test kit (colloidal gold) Angiten-covid-19 virus test kit (colloidal gold) Angiten-covid-19 virus test kit (colloidal gold) Angiten-covid-19 virus test kit (colloidal gold)
Access Bio Care Start Covid-19 Rapid Antigen Test Kit Product Details: Number of Reactions(Preps) per Kit : 1 Brand : Access Bio Test Method : Antigen Test Result Time (Rapid Kits) : 10 min Sample Type ; Nasal Swab Packaging Size : 20 Test Kits/Box Packaging Type : Box The CareStart COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between
